The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
HCA (HCA) could produce exceptional returns because of its solid growth attributes.
Here is how HCA Healthcare (HCA) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year.
HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HCA Healthcare's Q3 earnings rise 42% y/y on stronger patient volumes and rising inpatient surgeries, prompting management to lift its 2025 outlook.
HCA Healthcare, Inc. delivered strong Q3 results, beating earnings and revenue expectations, and raised full-year guidance. Despite HCA's outperformance and robust technicals, shares are now near fair value, prompting a downgrade from buy to hold. Upside is limited by valuation, with risks including labor costs, Medicaid changes, and industry competition, though fundamentals remain solid.
HCA Healthcare lifted its full-year outlook after logging higher profit and revenue in the third quarter, as same-facility admissions grew.
HCA's Q3 earnings to witness solid revenue growth, but rising expenses may weigh on results.
HCA Healthcare, Inc. (NYSE:HCA ) Healthcare, Inc. Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 2:15 PM EDT Company Participants Mike Marks - CFO & Executive VP Conference Call Participants Stephen Baxter - Wells Fargo Securities, LLC, Research Division Presentation Stephen Baxter Senior Equity Analyst Alright. So good afternoon, everyone.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.